Clinical Trial Update: Exploratory Study of Biotelemetry in Amyotrophic Lateral Sclerosis [NA]

View source ↗

Summary

Exploratory biotelemetry study in amyotrophic lateral sclerosis completed; results posted in 2018.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Amyotrophic Lateral Sclerosis

Snippet

Sponsor: GlaxoSmithKline | Conditions: Amyotrophic Lateral Sclerosis | NA | Status: COMPLETED | Results posted: 2018-12-26